Nicholas C. Yoder
Impact in
- Pharmaceutical Science top 2%
- Fluorine in Organic Chemistry
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in ⓘ
- Co-authors
- Krishna Kumar (10 shared papers)Hidde L. Ploegh (3 shared papers)Maximilian W. Popp (2 shared papers)Carla P. Guimarães (1 shared paper)Gijsbert M. Grotenbreg (1 shared paper)Guo-Liang Chew (1 shared paper)John M. Antos (1 shared paper)Martin D. Witte (2 shared papers)
- Journals
- Cancer Research (5 papers)Journal of the American Chemical Society (3 papers)Blood (2 papers)Bioconjugate Chemistry (2 papers)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Nicholas C. Yoder
28 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 197
- Oncology 333
- Organic Chemistry 326
- Radiology, Nuclear Medicine and Imaging 248
- Molecular Biology 714
Countries citing papers authored by Nicholas C. Yoder
This map shows the geographic impact of Nicholas C. Yoder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas C. Yoder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas C. Yoder more than expected).
Fields of papers citing papers by Nicholas C. Yoder
This network shows the impact of papers produced by Nicholas C. Yoder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas C. Yoder. The network helps show where Nicholas C. Yoder may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas C. Yoder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 285 | |
| 2 | 2009 | 207 | |
| 3 | 2018 | 129 | |
| 4 | 2012 | 115 | |
| 5 | 2016 | 65 | |
| 6 | 2006 | 54 | |
| 7 | 2013 | 33 | |
| 8 | 2013 | 31 | |
| 9 | 2007 | 31 | |
| 10 | 2019 | 30 | |
| 11 | 2011 | 30 | |
| 12 | 2008 | 28 | |
| 13 | 2019 | 20 | |
| 14 | 2005 | 20 | |
| 15 | 2016 | 17 | |
| 16 | 2016 | 13 | |
| 17 | 2019 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2008 | 7 | |
| 20 | 2007 | 6 |
About Nicholas C. Yoder
Nicholas C. Yoder is a scholar working on Virology, Oncology, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging and Biophysics, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Lipid Membrane Structure and Behavior (4 papers), Chemical Synthesis and Analysis (4 papers), RNA Interference and Gene Delivery (4 papers), HIV Research and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers) and Nanofabrication and Lithography Techniques (3 papers). The work is most often cited by research in Pharmaceutical Science (197 citations), Oncology (333 citations), Organic Chemistry (326 citations), Radiology, Nuclear Medicine and Imaging (248 citations) and Molecular Biology (714 citations). Nicholas C. Yoder has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Krishna Kumar, Hidde L. Ploegh, Maximilian W. Popp, Carla P. Guimarães, Gijsbert M. Grotenbreg, Guo-Liang Chew, John M. Antos, Martin D. Witte, Juan J. Cragnolini and Stephanie K. Dougan. Their work appears in journals such as Cancer Research, Journal of the American Chemical Society, Blood, Bioconjugate Chemistry and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.